# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1729 | cisapride | INH | = | 89 | % | ALA2422533 | % | Homo sapiens | |||
2. | ALA1729 | cisapride | pKi | = | 7 | ALA2404387 | 7.00 | nM | Homo sapiens | |||
3. | ALA1729 | cisapride | pEC50 | = | 7.1 | ALA2404386 | 7.10 | nM | Homo sapiens | |||
4. | ALA1729 | cisapride | Intrinsic activity | = | 71 | % | ALA2404385 | % | Homo sapiens | |||
5. | ALA1729 | cisapride | pKi | = | 5.7 | ALA2404383 | 5.70 | nM | Homo sapiens | |||
6. | ALA1729 | cisapride | INH | = | 100 | % | ALA2404382 | % | Homo sapiens | |||
7. | ALA1729 | cisapride | t1/2 | = | 47 | min | ALA2404381 | hr | Rattus norvegicus | |||
8. | ALA1729 | cisapride | pKi | = | 5.7 | ALA2406742 | 5.70 | nM | Homo sapiens | |||
9. | ALA1729 | cisapride | pKi | = | 6.9 | ALA2406740 | 6.90 | nM | Homo sapiens | |||
10. | ALA1729 | cisapride | Ratio pKi | = | 16 | ALA2406741 | ||||||
11. | ALA1729 | cisapride | pEC50 | = | 7 | ALA2406739 | 7.00 | nM | Cavia porcellus | |||
12. | ALA1729 | cisapride | Intrinsic activity | = | 75 | % | ALA2406735 | % | Cavia porcellus | |||
13. | ALA1729 | cisapride | pKi | = | 6.1 | ALA2406729 | 6.10 | nM | Homo sapiens | |||
14. | ALA1729 | cisapride | pKi | = | 8.2 | ALA2406730 | 8.20 | nM | Homo sapiens | |||
15. | ALA1729 | cisapride | pKi | = | 7.4 | ALA2406727 | 7.40 | nM | Homo sapiens | |||
16. | ALA1729 | cisapride | pKi | = | 6 | ALA2406728 | 6.00 | nM | Homo sapiens | |||
17. | ALA1729 | cisapride | Activity | = | 2.66 | mg kg-1 | ALA2406725 | mg kg-1 | Rattus norvegicus | |||
18. | ALA1729 | cisapride | Ratio IC50 | < | 2 | ALA2071966 | Homo sapiens | |||||
19. | ALA1729 | cisapride | INH | 0 | ALA2071967 | Active | % | Homo sapiens | ||||
20. | ALA1729 | cisapride | Stability | 0 | ALA2071971 | Stable | % | Homo sapiens |